(19)
(11) EP 3 380 201 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
28.10.2020 Bulletin 2020/44

(45) Mention of the grant of the patent:
19.02.2020 Bulletin 2020/08

(21) Application number: 15820597.1

(22) Date of filing: 26.11.2015
(51) International Patent Classification (IPC): 
A61Q 19/08(2006.01)
A61K 8/9794(2017.01)
A61K 36/28(2006.01)
A61K 8/9789(2017.01)
A61K 36/8967(2006.01)
A61Q 17/00(2006.01)
(86) International application number:
PCT/IB2015/002367
(87) International publication number:
WO 2017/089854 (01.06.2017 Gazette 2017/22)

(54)

ANTI-POLLUTION COMPLEX COMPRISING OILY AND AQUEOUS CALENDULA EXTRACTS AND AN AQUEOUS EXTRACT OF LILIUM CANDIDUM BULB AND USES THEREOF

KOMPLEX GEGEN VERSCHMUTZUNG MIT ÖLIGEN UND WÄSSRIGEN CALENDULA-EXTRAKTEN UND EINEM WÄSSRIGEN EXTRAKT AUS LILIUM-CANDIDUM-ZWIEBELN UND VERWENDUNGEN DAVON

COMPLEXE ANTIPOLLUTION COMPRENANT DES EXTRAITS HUILEUX ET AQUEUX DE CALENDULA ET UN EXTRAIT AQUEUX DE BULBE DE LILIUM CANDIDUM ET UTILISATIONS DE CELUI-CI


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(43) Date of publication of application:
03.10.2018 Bulletin 2018/40

(73) Proprietor: MP2 Cosmetic Solutions
75004 Paris (FR)

(72) Inventor:
  • LECLERE, Jacques
    45500 Saint-Gondon (FR)

(74) Representative: Ipsilon 
Le Centralis 63, avenue du Général Leclerc
92340 Bourg-la-Reine
92340 Bourg-la-Reine (FR)


(56) References cited: : 
WO-A1-98/26755
FR-A- 1 249 468
WO-A1-99/16414
GB-A- 2 485 483
   
  • K.C. PREETHI ET AL: "Antioxidant Potential of an Extract of Calendula officinalis Flowers in Vitro and in Vivo .", PHARMACEUTICAL BIOLOGY, vol. 44, no. 9, 1 January 2006 (2006-01-01), pages 691-697, XP055274994, NL ISSN: 1388-0209, DOI: 10.1080/13880200601009149
  • ZITTERL-EGLSEER K ET AL: "Anti-oedematous activities of the main triterpenediol esters of marigold (Calendula officinalis L.)", JOURNAL OF ETHNOPHARMACOLOGY, ELSEVIER IRELAND LTD, IE, vol. 57, no. 2, 1 January 1997 (1997-01-01), pages 139-144, XP009151766, ISSN: 0378-8741
  • DATABASE GNPD [Online] MINTEL; 1 October 2011 (2011-10-01), Maxima Inc.: "Fleur Vibrante Face Balm Concentré", XP002758047, Database accession no. 1664221
  • DATABASE GNPD [Online] MINTEL; 1 August 2007 (2007-08-01), Dr. Müller Pharma: "Marigold Ointment", XP002758048, Database accession no. 759205
  • DATABASE GNPD [Online] MINTEL; 1 December 2009 (2009-12-01), Natura House: "Eye Contour Gel", XP002758049, Database accession no. 1222769
  • DATABASE GNPD [Online] MINTEL; 1 December 2008 (2008-12-01), Laboratoire Alpaderm: "Nourishing Cream", XP002758050, Database accession no. 1024600
  • AGELESS HERBAL PRODUCTS: "Information on white lily - Lilium candidum", INTERNET CITATION, 23 October 2005 (2005-10-23), pages 1-4, XP002738745, Retrieved from the Internet: URL:http://wayback.archive.org/web/2005102 3105011/http://www.ageless.co.za/herb-lily .htm [retrieved on 2015-04-21]
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).